Royal jelly restores age-related decline in stem cell function through a mechanism involving increased CD206-positive macrophages and Chi3l1 signaling. This finding identifies a tractable pathway for mitigating cellular regeneration loss—a hallmark of aging—using a naturally derived compound.
Key Points
- Royal jelly reverses stem cell dysfunction associated with aging
- Chi3l1 signaling drives macrophage polarization supporting regeneration
- CD206-positive macrophages mediate tissue repair and stem cell recovery
Longevity Analysis
Stem cell exhaustion is a primary mechanism underlying age-related tissue degeneration and loss of functional capacity. By demonstrating that royal jelly restores stem cell competence through macrophage-mediated immunological signaling, this research points to the critical interplay between immune regulation and regenerative capacity. The ability to decode signals of macrophage dysfunction and polarize them toward a pro-regenerative state offers a specific intervention point for sustaining tissue repair capacity across multiple organs—without pharmaceutical toxicity or complex delivery systems. This bridges immune function and cellular regeneration in a way that addresses fundamental aging biology rather than treating downstream consequences.
Original published by Nature - npj Aging, by Yukie Kande.